Abstract
This paper demonstrates a so far ignored negative externality imposed by the provision of fife prolonging drugs to infected carriers of infectious diseases. Private optimal usage tends to imply socially inefficient over-provision of life enhancing infectious disease medication. (C) 2003 Elsevier Science B.V. All rights reserved.
| Original language | English |
|---|---|
| Pages (from-to) | 61-66 |
| Number of pages | 5 |
| Journal | Economics Letters |
| Volume | 80 |
| Issue number | 1 |
| DOIs | |
| Publication status | Published - Jul 2003 |
Keywords
- epidemics
- externalities
- drug provision
- VACCINATION
- PRIVATE
